FDA-cleared TMS Target potential buyers interested in non-pharmacological depression treatment by highlighting NeuroSpa TMS’s use of FDA-cleared Transcranial Magnetic Stimulation as a medication-free option, and position conversations around improving patient outcomes with fewer side effects.

Mid-market Focus Opportunity to partner with clinics or health systems in the mental health space that operate in mid-sized markets, given NeuroSpa TMS’s team size (11-50 employees) and revenue range, suggesting flexibility for scalable service offerings or referral arrangements.

Competitive Positioning Differentiate on side-effect free treatment to compete against pharmacotherapy and propose value-based conversations with practices seeking outcomes-driven care, leveraging NeuroSpa’s emphasis on restoring healthy brain function.

Regional Growth Leverage Tampa Bay-area base to target regional expansion opportunities in Florida and neighboring states, offering turnkey deployment support, training, and patient acquisition services aligned with local demand for TMS therapy.

Digital Enablement Align with NeuroSpa’s tech stack and web capabilities to propose digital marketing, patient scheduling optimization, and telehealth-enabled follow-ups, enhancing patient outreach and operational efficiency for growth.